Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Moving annual total (MAT)
The total value of a variable, such as sales figures for a product, over the course of the previous 12 months. This is a rolling yearly sum, so changes at the end of each month with data from the new month added to the total and data from the first month of the period taken away.
See also:
Cost–benefit analysis
Cost-minimisation analysis (CMA)
Cost consequences analysis (CCA)
Related terms
Joint venture, Merger and Acquisition (M&A), Marginal cost, Payback period, Return on equity (ROE), Incremental cost-effectiveness ratio (ICER), Economic value added (EVA) , Discounted cash flow (DCF), Portfolio analysis, Marginal analysis, Demand curve, Quantitative objectives, Critical success factors, Key success factor (KSF), Market forecast,
Subscribe to our email news alerts
Featured jobs
- Business Development Director, Medical Education - exciting new ...
-
Up to £120K base
- Scientific Team Leader, Scientific Services, Medical Communicati...
-
Highly competitive salary
- Associate Vice President, Scientific Services, Medical Communica...
-
Highly competitive salary
- Commercial Director, Medical Education, UK six figure package
-
Six figure salary
- Amylyx’s Relyvrio receives FDA approval for ALS treatment
- Cancer Research UK scientists announce ‘breakthrough’ in understanding of metastasis
- Biogen and Eisai’s lecanemab shows promise in confirmatory Alzheimer’s study
- NHS England launches lung cancer awareness drive in country’s cancer hotspots
- Dexcom launches next-generation continuous glucose monitor for diabetes patients
- Sanofi and Regeneron’s Dupixent approved by FDA for prurigo nodularis
- Onyx Health Goes for International Growth with New Managing Director
- Live Webinar: Closing the Gaps in Telehealth
- Lifting the fog to help Clinical Labs navigate IVDR 2022
- Empowering adolescents to manage emotional and mental health issues
- Reframing rare to increase earlier diagnosis of Gaucher Disease
- Proving the power of a positive mindset to help fix all ills
- Biogen to pay $900m to settle whistleblower’s MS drug kickback lawsuit
- Envision Pharma Group appoints new CEO
- The value of patient reported outcomes
- Bristol Myers Squibb’s active ulcerative colitis treatment bags NICE recommendation
- COVID-19 linked to long-term neurologic disorders in new US study
- Crestor can't top Lipitor in head-to-head study
